Nadolol Tablet
Product Images NDC 69097-867

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nadolol (NDC 69097-867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nadolol 20mg 100c Cl

Nadolol 20mg 100c Cl
This is a prescription drug called Nadolol Tablets, USP, with 100 tablets in each bottle. Each tablet contains 20mg of nadolol, USP. The drug is made by InvaGen Pharmaceuticals Inc, a subsidiary of Cipla Ltd, and is distributed by Cipla USA Inc. The drug is to be protected from light, and stored at a controlled room temperature of 20°C to 25°C. The product has a lot number of XXX0UO0KX and an expiration date of MM/YYYY.*
FDA Label Image

Nadolol 40mg 100c Cl

Nadolol 40mg 100c Cl
This is a description of a medication called "Nadolol." It contains 100 tablets with 40mg of nadolol, a beta-blocker medication used to lower blood pressure and treat angina. The drug is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd. and is designed for prescription-only use. The tablets should be stored at 20° to 25°C and protected from light. The product also suggests reviewing accompanying literature for dosing information.*
FDA Label Image

Nadolol 80mg 100c Cl

Nadolol 80mg 100c Cl
This is a description of Nadolol tablets, a prescription-only medication that comes in a bottle containing 100 tablets. Each tablet contains 80mg of Nadolol, a beta-blocker used to treat high blood pressure, chest pain, and other conditions. The medication should be stored at controlled room temperature and kept away from light sources. The dosage information can be found in the product literature. The tablets are manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Limited, and are distributed by Cipla USA.*
FDA Label Image

Nadolol Str

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.